Personalized letters could ease skin cancer patient worries
NCT ID NCT07330323
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a personalized discharge letter helps low-risk skin cancer patients feel more reassured and understand their condition better. About 150 patients will receive either standard advice or a tailored letter generated by an AI system and reviewed by a doctor. The goal is to improve patient knowledge and confidence in self-checks without overwhelming them with generic information.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW RISK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UZLeuven, Department of Dermatology
RECRUITINGLeuven, Vlaams-Brabant, 3000, Belgium
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can your genes predict your melanoma risk?
- A UV photo and a cheek swab may be the keys to stopping sunburn before it starts
- Night shift workers' skin may struggle to fix sun damage, study suggests
- What makes skin cancer patients happy after surgery?
- Alpha radiation seeds target tumors from the inside
- AI reads social media posts to spot suicide risk in skin cancer patients